Clinical Trial Update: Establishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal Cancer

View source ↗

Summary

This clinical trial update outlines a study to establish a circulating tumor DNA biomarker to improve organ-preserving strategies in rectal cancer. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma
• Rectal Cancer

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Rectal Adenocarcinoma, Stage II Rectal Cancer AJCC v8 | Status: RECRUITING